FREE CASE EVALUATION

Prominently Featured In:

CNN
Netflix
Newsweek
Business Insider
Time

What Should I Do When a Commercial Insurance Carrier Wants to Audit My Patient Charts

An insurance audit is not a routine administrative interaction when it focuses on controlled substance prescribing. It is an adversarial proceeding with legal consequences, and it should be treated as one from the moment the request arrives.

Commercial insurance carriers, Medicare Administrative Contractors, and Medicaid managed care organizations have contractual and regulatory authority to audit the records of providers who participate in their networks or programs. That authority is real. The audit is not optional. But the practitioner’s obligation to comply with an audit does not require compliance without preparation, without counsel, or without a clear understanding of what the audit’s scope and purpose actually are.

Understanding the Audit’s Character

Not all audits are equivalent. A routine audit of a random sample of claims for documentation sufficiency is a different proceeding from a focused audit of a specific category of prescriptions, a specific time period, or a specific patient population. The character of the audit request, including which claims are selected, which documentation is sought, and which unit of the carrier is conducting the review, provides information about whether the audit is routine or investigative.

An audit conducted by the carrier’s Special Investigations Unit, or that focuses specifically on Schedule II or III controlled substance prescriptions, or that requests records for the same time period that a DEA inquiry has identified, is an audit that may have been initiated in coordination with a government investigation or that may generate a government referral when its findings are complete. The carrier is not required to disclose whether its audit is connected to a government investigation. The practitioner is not required to ask before retaining counsel.

Retain Counsel Before Responding

The audit response deadline in the carrier’s request is typically thirty to sixty days from the date of the request. That interval is sufficient to retain counsel, conduct a privileged review of the records at issue, identify any records that raise compliance concerns, and develop a response strategy that complies with the audit’s requirements while protecting the practitioner’s legal position.

Counsel experienced in healthcare compliance and government investigations should review the audit request before any records are produced. That review addresses several questions: whether the audit is within the scope of the carrier’s contractual audit authority; whether the records requested are subject to any privilege or other protection; whether the records, when reviewed, reveal compliance issues that should be addressed before or alongside the audit response; and whether the audit’s scope suggests a government investigation that warrants independent legal attention.

Reviewing the Records Before Producing Them

Every record produced in an audit should be reviewed before it is produced. The practitioner who produces records without reviewing them has produced a set of documents whose contents they have not assessed for accuracy, completeness, or consistency with the billing that was submitted. Records that are inconsistent with the billed services, that are underdeveloped relative to the complexity of the encounter they document, or that reflect documentation practices that do not meet the carrier’s requirements are records that will be identified in the audit and that may generate a demand for repayment or a referral to the government.

FREE CONSULTATION

Need Help With Your Case?

Don't face criminal charges alone. Our experienced defense attorneys are ready to fight for your rights and freedom.

  • 100% Confidential
  • Response Within 1 Hour
  • No Obligation Consultation

Or call us directly:

(212) 300-5196

The review of records before production is not an opportunity to alter or supplement those records in a manner that makes them more favorable. Adding documentation to patient records after the audit has been initiated, or modifying records to reflect clinical activity that did not occur as documented, constitutes record falsification and creates obstruction and fraud exposure that is far more severe than any adverse audit finding the original records would have generated.

The review is an assessment of what the records show, what the audit is likely to find, and what the practice’s legal position is with respect to each finding the audit may produce. That assessment informs the response strategy.

Responding to Adverse Findings

If the audit produces findings that the carrier characterizes as documentation deficiencies, billing irregularities, or inappropriate prescribing, the practitioner has the right to appeal those findings through the carrier’s administrative appeal process. The appeal is not a formality. It is an adversarial proceeding in which the practitioner has the opportunity to present clinical and legal arguments challenging the audit’s methodology, the standards it applied, and the conclusions it reached.

Carrier audit findings that result in repayment demands may also trigger exclusion proceedings under the Medicare and Medicaid exclusion statutes if the audit findings are referred to the Office of Inspector General. Exclusion from Medicare and Medicaid participation effectively ends a healthcare practice that depends on federal program reimbursement, and the exclusion proceeding is separate from any criminal investigation that may arise from the same underlying conduct.

Todd Spodek
DEFENSE TEAM SPOTLIGHT

Todd Spodek

Lead Attorney & Founder

Featured on Netflix's "Inventing Anna," Todd Spodek brings decades of high-stakes criminal defense experience. His aggressive approach has secured dismissals and acquittals in cases others deemed unwinnable.

NY Bar Admitted Multi-State Licensed Federal Courts
Meet the Full Team

The carrier audit that arrives without warning is the one for which preparation is hardest. The carrier audit that arrives after the practitioner has been monitoring their billing patterns, maintaining thorough documentation, and conducting internal compliance reviews is the one for which the response is most straightforward. The difference between those two situations is entirely a function of what happened in the months before the audit request arrived.

When the Audit Reveals Government Involvement

Some audits reveal government involvement explicitly: the carrier notifies the practitioner that it has referred its findings to the OIG, the DOJ, or a state agency. Others reveal it implicitly through the timing and focus of the audit relative to other indicators of investigation. Either way, the moment at which a carrier audit intersects with a government investigation is the moment at which the practitioner’s response strategy must account for both proceedings simultaneously.

The insurance carrier and the government are not the same entity, but they share information, refer matters to each other, and may be pursuing related investigations based on the same underlying prescribing data. Managing the audit response in a way that does not inadvertently worsen the practitioner’s position in the government investigation requires counsel who understands both dimensions of the exposure and can coordinate the response to each.

Share This Article:
Todd Spodek
ABOUT THE AUTHOR

Todd Spodek

Managing Partner

With decades of experience in high-stakes federal criminal defense, Todd Spodek has built a reputation for aggressive, strategic representation. Featured on Netflix's "Inventing Anna," he has successfully defended clients facing federal charges, white-collar allegations, and complex criminal cases in federal courts nationwide.

Bar Admissions: New York State Bar New Jersey State Bar U.S. District Court, SDNY U.S. District Court, EDNY
View Attorney Profile

Community Discussion

Real questions and discussions from readers about this topic.

57
FF former_fed_investigator Former Federal Agent 2w ago

Former investigator perspective on this topic

Retired FBI healthcare fraud agent here. Spent 15 years on the enforcement side. Reading this article and the comments — I want to offer some perspective from the other side of the table.

Most investigations start with data, not complaints. PDMP data, Medicare billing data, pharmacy purchasing records. By the time an agent contacts you, they've usually been looking at your numbers for months. That's why having good documentation matters — the data will flag you, but the documentation either explains the data or doesn't.

57
RD retired_DEA_agent Former Federal Agent 2w ago

Talking. Hands down. Doctors who talked to agents without a lawyer — trying to explain their way out of it — gave us 80% of the evidence we needed. Every single time. Get a lawyer first. Always.

48
HD healthcare_defense_atty Attorney 2w ago

Seconding this emphatically. I've represented dozens of healthcare providers. The ones who called me BEFORE talking to agents had dramatically better outcomes than the ones who called AFTER. It's not about having something to hide — it's about having your rights protected from the start.

32
WP worried_physician Physician 2w ago

This is incredibly valuable perspective. Can you share — what's the single biggest mistake you saw doctors make when they first learned they were being investigated?

42
SO spouse_of_doc 1w ago

My wife is a doctor and I’m terrified after reading this

My spouse is a primary care physician and got a call from a federal agent last week. We have two young kids. I don't know anything about criminal defense. How do we even start? How much does this cost? Can they take our house?

45
FM fed_med_lawyer Attorney 1w ago

I understand the fear. Here's what you need to know:

1. Attorney fees: Federal healthcare fraud defense typically costs $20,000-60,000 depending on the stage and complexity. Pre-investigation work is on the lower end.

2. Your home: In most states, homestead exemptions protect your primary residence. Federal forfeiture requires a direct connection between the property and the alleged criminal activity — simply being a doctor who's investigated doesn't put your house at risk.

3. First step: Call a federal healthcare fraud defense attorney this week. Not a general lawyer. Someone who has handled DEA/OIG cases before. Most will do a free phone consultation to assess the situation.

4. Don't panic: Investigation ≠ charges. Charges ≠ conviction. Many investigations are closed without action.

27
BT been_there_doc 1w ago

I'm the spouse of a physician who went through a 2-year DEA investigation. It was resolved favorably. The emotional toll is real — please consider therapy for both of you. We found a support group for medical professionals under investigation that helped enormously. You're not alone in this.

36
AD anxious_doc_2025 Physician 2w ago

Going through exactly what this article describes — anyone else?

Just read this article about "What Should I Do When a Commercial Insurance Carrier Wants to Audit My Patient Charts" and it hit close to home. I'm a anesthesiologist and I've been losing sleep over this. My prescribing patterns got flagged by the state PDMP. I haven't been contacted directly by any agency yet but the anxiety is crushing. Anyone been through something similar?

44
FM fed_med_lawyer Attorney 2w ago

First: do NOT speak to any federal agent without counsel. Period. Not the DEA, not the OIG, not the FBI. You have the right to counsel and exercising that right cannot be held against you.

Second: get a consultation NOW, before anything formal happens. Pre-investigation counsel is dramatically more effective (and less expensive) than post-indictment defense. Many healthcare fraud defense attorneys offer free initial consultations.

Third: do NOT alter any records. Do NOT destroy any documents. Do NOT discuss this with staff beyond what's necessary for patient care. Any of those actions can become separate criminal charges (obstruction, evidence tampering) even if the underlying prescribing was entirely legitimate.

41
BT been_there_doc Physician — Investigated & Cleared 2w ago

Went through a DEA investigation 3 years ago. It was the worst 18 months of my life but I came out clean. Best advice: get a lawyer who specifically handles federal healthcare cases (not a general criminal attorney), follow their instructions to the letter, and keep practicing medicine. The investigation itself is not a conviction and most of your patients still need you.

28
PC pharma_compliance Compliance 2w ago

If you haven't already, start documenting everything meticulously going forward. Every prescribing decision should have clear clinical justification in the chart. This protects you regardless of whether an investigation materializes.

34
KC ketamine_clinic_owner Anesthesiologist 1w ago

Anyone running a ketamine clinic dealing with these issues?

I operate a ketamine infusion clinic and the regulatory landscape feels like it changes monthly. A patient's family filed a complaint about our treatment approach. How are other ketamine providers navigating this?

32
HD healthcare_defense_atty Attorney 1w ago

Ketamine clinics are an emerging enforcement target. The Schedule III classification gives you more flexibility than Schedule II, but the "legitimate medical purpose" standard still applies. The biggest risk areas I see: (1) inadequate patient screening, (2) lack of follow-up care, (3) advertising that makes medical claims beyond what's supported, (4) corporate practice of medicine violations if non-physicians have ownership stakes. Get a compliance review done proactively.

26
FK fellow_ketamine_doc Psychiatrist 1w ago

Running a ketamine clinic since 2021. The key is airtight protocols and documentation. We have:
- Written treatment protocols for every indication
- Informed consent that specifically addresses off-label use
- Pre-treatment screening including psychological evaluation
- Monitoring during and after infusion
- Follow-up documentation
- Clear exclusion criteria

The DEA has been more interested in compounding pharmacies than individual clinics so far, but that could change. Stay current with ASA and APA guidelines.

30
SD solo_doc_2025 Solo Practitioner 2w ago

How much does a federal healthcare fraud attorney actually cost?

I need to talk to someone but I'm a solo practitioner. I don't have a hospital legal department behind me. What does it actually cost to retain a federal healthcare defense attorney? Just a consultation vs. ongoing representation? Can I even afford this?

46
FM fed_med_lawyer Attorney 1w ago

Typical ranges:

- Initial consultation: Free to $500. Many firms offer free phone consultations.
- Pre-investigation advisory/compliance review: $3,000–$10,000
- Responding to a subpoena: $5,000–$15,000
- Full investigation representation: $25,000–$75,000+
- Trial defense: $100,000–$500,000+

The earlier you engage, the less it costs. A $5,000 consultation that prevents a $50,000 investigation is the best money you'll ever spend. Most attorneys will work out payment plans for solo practitioners.

29
SI survived_investigation Physician — Investigated & Cleared 1w ago

I paid about $35k total for my defense over 18 months. Was it painful? Yes. Would I do it again? In a heartbeat. The alternative — trying to handle it myself or hiring a cheap general attorney — would have cost me my license and my freedom.

28
PW PA_worried_about_DEA Nurse Practitioner 1w ago

Does this apply to NPs and PAs too, or just physicians?

I'm a nurse practitioner with prescriptive authority. Does what this article discusses about "What Should I Do When a Commercial Insur" apply equally to mid-level providers? I prescribe psychiatric medications including benzos under my collaborating physician's DEA number. If something goes wrong, who is at risk — me, the supervising physician, or both?

33
HD healthcare_defense_atty Attorney 1w ago

Both. If you have your own DEA registration, you bear independent responsibility for your prescribing. If you're prescribing under a collaborating physician's DEA number, the supervising physician also has exposure. The DEA does not limit investigations to physicians — NPs, PAs, dentists, podiatrists, and veterinarians have all been targets of federal prescribing investigations.

The same standard applies: prescriptions must be issued for a legitimate medical purpose in the usual course of professional practice. Document your clinical reasoning for every controlled substance prescription.

14
NC NP_colleague PA-C 1w ago

I got my own DEA number specifically so I wouldn't be dragged into my collaborating physician's issues. Worth considering if you haven't already. It also makes your prescribing cleaner from a documentation standpoint.

24
NA new_attending_2025 New Attending 1w ago

Just started practice — is this something I should worry about from day one?

I just finished residency and started at a private pain clinic. Reading about "What Should I Do When a Commercial Insur" is terrifying for someone just starting out. Should I be getting my own malpractice attorney from day one? What should I be doing differently as a new practitioner to protect myself?

40
BT been_there_doc Physician — 20yr 1w ago

The fact that you're thinking about this early is a good sign. Three things:\n\n1. Document meticulously. Every prescribing decision should have clear clinical justification. "Patient reports pain" is not enough. Physical exam findings, functional assessments, treatment plans.\n\n2. Get familiar with your state PDMP and check it for every controlled substance prescription. Make it a habit from day one.\n\n3. Find a mentor in your practice who models good prescribing practices. Observe how they handle difficult patients, how they document, how they say no when needed.\n\nYou don't need a defense attorney on retainer, but knowing who you'd call if needed is smart.

27
HD healthcare_defense_atty Attorney 1w ago

I'll add: make sure your malpractice insurance includes regulatory defense coverage (not just civil malpractice). Many policies exclude coverage for DEA/licensing board actions. Ask your carrier specifically. If they don't cover it, supplemental regulatory defense insurance is available and relatively inexpensive for new practitioners.

18
DD dental_doc DVM 3w ago

Does this apply to veterinarians too?

I'm a podiatrist who prescribes controlled substances. Most of the articles I see focus on physicians and pain management. Are dentists really at risk for DEA scrutiny?

21
HD healthcare_defense_atty Attorney 3w ago

Yes. Any DEA registrant who prescribes controlled substances is subject to the same federal standards. Dentists are increasingly scrutinized for opioid prescribing — the CDC's prescribing guidelines have been applied to dental practice. Veterinarians have seen a rise in diversion cases (drugs prescribed for animals being diverted to human use). The DEA does not distinguish by specialty — they look at prescribing patterns and whether they're consistent with legitimate medical practice.

Ask the Community

Federal Lawyers By The Numbers

36 Cases Handled This Year and counting
15,536+ Total Clients Served since 2005
95% Case Success Rate dismissals & reduced charges
50+ Years Combined Experience in criminal defense

Data as of February 2026

URGENT

Take Control of Your Situation

Our team is standing by to discuss your legal options

Get Advice From An Experienced Criminal Defense Lawyer

All You Have To Do Is Call (212) 300-5196 To Receive Your Free Case Evaluation.